Levels of lipoprotein(a) [Lp(a)] need to be reduced by substantially more than has been achieved in recent trials

Levels of lipoprotein(a) [LP(a)] need to be reduced substantially in order to have the same impact on coronary heart disease (CHD) risk as that seen with relatively modest reductions of low-density lipoprotein (LDL) cholesterol, suggests a large-scale analysis of trial data.

Source: Medscape

Read this article

 

Related stories